Please use this identifier to cite or link to this item:
Title: Exploring inhibitors and vitamins to generate tolerogenic dendritic cells for Multiple Sclerosis
Authors: Vanhees, Mandy
Advisors: HELLINGS, Niels
Issue Date: 2012
Publisher: tUL Diepenbeek
Abstract: Not only are dendritic cells (DC) the main inducers of a primary T cell response, they also determine the profile of that response. This makes DC interesting immune modulating agents. In Multiple Sclerosis (MS), tolerogenic DC could be used to restore tolerance. To date, there is no consensus concerning the stimuli that produce that type of DC. We therefore hypothesized that treatment of DC with specific stimuli generates tolerogenic DC able to restore the immune balance in EAE mice, an MS animal model. In this study, 3 stimuli were compared. Treatment of immature DC with SAHA produced semi-mature DC after LPS challenge, with reduced expression of co-stimulatory molecules and decreased secretion of pro-inflammatory cytokines. Bone marrow treatment with active vitamin D3 also lowered co-stimulatory molecule expression. Treatment of EAE mice with Captopril-treated DC was insufficient to block EAE development. We conclude that SAHA is the stimulus with the most DC tolerizing potential.
Notes: master in de biomedische wetenschappen-klinische moleculaire wetenschappen
Document URI:
Category: T2
Type: Theses and Dissertations
Appears in Collections:Master theses

Files in This Item:
File Description SizeFormat 
07255382011249.pdf2.46 MBAdobe PDFView/Open
Show full item record

Page view(s)

checked on May 20, 2022


checked on May 20, 2022

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.